Definitive Healthcare (NASDAQ:DH) Updates Q2 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its second quarter earnings guidance on Tuesday. The company provided earnings per share guidance of $0.08-$0.09 for the period, compared to the consensus earnings per share estimate of $0.09. The company issued revenue guidance of $62.0-$63.5 million, compared to the consensus revenue estimate of $65.19 million. Definitive Healthcare also updated its FY24 guidance to $0.36-$0.38 EPS.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Canaccord Genuity Group increased their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the company a hold rating in a research note on Thursday, February 29th. Needham & Company LLC downgraded shares of Definitive Healthcare from a buy rating to a hold rating in a research note on Wednesday, January 17th. Barclays increased their price objective on shares of Definitive Healthcare from $10.00 to $11.00 and gave the company an equal weight rating in a research note on Friday, March 1st. Finally, Stifel Nicolaus dropped their price objective on shares of Definitive Healthcare from $12.00 to $11.00 and set a buy rating on the stock in a research note on Wednesday, January 17th. Seven research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $11.31.

Definitive Healthcare Stock Down 1.2 %

Shares of NASDAQ:DH traded down $0.09 during trading hours on Tuesday, reaching $7.25. The stock had a trading volume of 480,437 shares, compared to its average volume of 560,899. Definitive Healthcare has a 1 year low of $5.53 and a 1 year high of $12.45. The firm’s 50 day moving average is $7.82 and its 200-day moving average is $8.31. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The stock has a market capitalization of $853.98 million, a price-to-earnings ratio of -4.07, a P/E/G ratio of 6.12 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The business had revenue of $65.93 million for the quarter, compared to analyst estimates of $66.01 million. Research analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.